Cargando…

New Features about Tau Function and Dysfunction

Tau is a brain microtubule-associated protein that directly binds to a microtubule and dynamically regulates its structure and function. Under pathological conditions, tau self-assembles into filamentous structures that end up forming neurofibrillary tangles. Prominent tau neurofibrillary pathology...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina, Miguel, Hernández, Félix, Avila, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919916/
https://www.ncbi.nlm.nih.gov/pubmed/27104579
http://dx.doi.org/10.3390/biom6020021
_version_ 1782439321743130624
author Medina, Miguel
Hernández, Félix
Avila, Jesús
author_facet Medina, Miguel
Hernández, Félix
Avila, Jesús
author_sort Medina, Miguel
collection PubMed
description Tau is a brain microtubule-associated protein that directly binds to a microtubule and dynamically regulates its structure and function. Under pathological conditions, tau self-assembles into filamentous structures that end up forming neurofibrillary tangles. Prominent tau neurofibrillary pathology is a common feature in a number of neurodegenerative disorders, collectively referred to as tauopathies, the most common of which is Alzheimer’s disease (AD). Beyond its classical role as a microtubule-associated protein, recent advances in our understanding of tau cellular functions have revealed novel insights into their important role during pathogenesis and provided potential novel therapeutic targets. Regulation of tau behavior and function under physiological and pathological conditions is mainly achieved through post-translational modifications, including phosphorylation, glycosylation, acetylation, and truncation, among others, indicating the complexity and variability of factors influencing regulation of tau toxicity, all of which have significant implications for the development of novel therapeutic approaches in various neurodegenerative disorders. A more comprehensive understanding of the molecular mechanisms regulating tau function and dysfunction will provide us with a better outline of tau cellular networking and, hopefully, offer new clues for designing more efficient approaches to tackle tauopathies in the near future.
format Online
Article
Text
id pubmed-4919916
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49199162016-06-24 New Features about Tau Function and Dysfunction Medina, Miguel Hernández, Félix Avila, Jesús Biomolecules Review Tau is a brain microtubule-associated protein that directly binds to a microtubule and dynamically regulates its structure and function. Under pathological conditions, tau self-assembles into filamentous structures that end up forming neurofibrillary tangles. Prominent tau neurofibrillary pathology is a common feature in a number of neurodegenerative disorders, collectively referred to as tauopathies, the most common of which is Alzheimer’s disease (AD). Beyond its classical role as a microtubule-associated protein, recent advances in our understanding of tau cellular functions have revealed novel insights into their important role during pathogenesis and provided potential novel therapeutic targets. Regulation of tau behavior and function under physiological and pathological conditions is mainly achieved through post-translational modifications, including phosphorylation, glycosylation, acetylation, and truncation, among others, indicating the complexity and variability of factors influencing regulation of tau toxicity, all of which have significant implications for the development of novel therapeutic approaches in various neurodegenerative disorders. A more comprehensive understanding of the molecular mechanisms regulating tau function and dysfunction will provide us with a better outline of tau cellular networking and, hopefully, offer new clues for designing more efficient approaches to tackle tauopathies in the near future. MDPI 2016-04-19 /pmc/articles/PMC4919916/ /pubmed/27104579 http://dx.doi.org/10.3390/biom6020021 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Medina, Miguel
Hernández, Félix
Avila, Jesús
New Features about Tau Function and Dysfunction
title New Features about Tau Function and Dysfunction
title_full New Features about Tau Function and Dysfunction
title_fullStr New Features about Tau Function and Dysfunction
title_full_unstemmed New Features about Tau Function and Dysfunction
title_short New Features about Tau Function and Dysfunction
title_sort new features about tau function and dysfunction
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919916/
https://www.ncbi.nlm.nih.gov/pubmed/27104579
http://dx.doi.org/10.3390/biom6020021
work_keys_str_mv AT medinamiguel newfeaturesabouttaufunctionanddysfunction
AT hernandezfelix newfeaturesabouttaufunctionanddysfunction
AT avilajesus newfeaturesabouttaufunctionanddysfunction